Healionics is addressing the critical need for safer, more reliable means of bloodstream access to perform dialysis in patients with kidney failure. Our STARgraft vascular graft (synthetic blood vessel) is designed to resist the problems of occlusion and infection suffered by current devices. We also have an exciting product pipeline based on our platform STARĀ® biomaterial, which has a unique ability to prevent two serious problems that affect all implantable devices: scarring and infection. The company is currently conducting human studies of STARgraft and has 36 patents issued or pending.
View Top Employees from Healionics CorporationWebsite | http://www.healionics.com |
Revenue | $1 million |
Employees | 10 (9 on RocketReach) |
Founded | 2007 |
Address | 2121 N. 35th Street Suite 200, Seattle, Washington 98103, US |
Phone | (206) 432-9060 |
Fax | (206) 432-9099 |
Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
Industry | Medical Devices, Medical Devices & Equipment, Biotechnology, Manufacturing, Science and Engineering, Health Care, Medical, Medical Device |
Competitors | Biomerix Corporation, Bonalive Biomaterials, FzioMed, Inc., Regenity Biosciences (Formerly Polyganics) |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Healionics Corporation employee's phone or email?
The Healionics Corporation annual revenue was $1 million in 2024.
9 people are employed at Healionics Corporation.
Healionics Corporation is based in Seattle, Washington.
The NAICS codes for Healionics Corporation are [339, 33].
The SIC codes for Healionics Corporation are [873, 87].